Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and CardioSert micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; transformational self-propelled and semi-disposable locomotive device to treat capabilities within tubular lumens in the human body, such as the colon, blood vessels, and the urinary tract; and a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery. As of April 23, 2019, it had 32 issued/allowed patents and 19 patent applications pending worldwide Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/11/2019 12:42 PDT] Microbot Medical Inc. (NASDAQ:MBOT), Up By 100.00% ($4.62) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, June 12th 2019 at a Price of $4.618.
• [06/19/2019 09:25 PDT] MBOT Expected to Trade Up After Bullish Patterns Develop
• [06/12/2019 08:16 PDT] MBOT SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/21/2019 21:21 PDT] Market Maker Surveillance Report. MBOT, Losing Stocks With Lowest Price Friction For Tuesday, May 21st 2019